We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




ECG Vest Allows For Non-Intrusive, Non-Invasive Heart Monitoring

By HospiMedica International staff writers
Posted on 04 Jan 2024

An arrhythmia, an irregular heartbeat, can lead to serious health issues like blood clots, stroke, and heart failure. More...

Traditional methods for monitoring such arrhythmia, like the Holter monitor, have limitations in terms of wearability and duration, typically offering only a 24- or 48-hour observation window. More long-term solutions tend to be invasive, requiring anesthesia for insertion. Now, an ECG monitoring system integrated into a T-shirt can accurately and non-invasively monitor the patient’s heart for weeks or months.

PA Consulting (London, UK) has developed Viscero, a revolutionary approach to ECG monitoring that integrates sensory technology seamlessly into a vest, allowing for effortless capture and transmission of diagnostic-quality data. The system positions dry electrodes in peripheral locations away from the chest, ensuring constant compression points for accurate readings. The brain behind Viscero, similar in size to a matchbox, conveniently fits into a pocket on the T-shirt. This allows for easy removal for recharging purposes or when the T-shirt needs washing. Additionally, Viscero is equipped with an onboard accelerometer and gyroscope, enriching the heart signal data with contextual information about the wearer's physical activities preceding an arrhythmic event.

This comprehensive data is accessible to healthcare professionals through an AI-enhanced dashboard that categorizes recordings into potential arrhythmic episodes, facilitating efficient review by cardiologists and significantly reducing the time spent analyzing ECG recordings. Patients can also engage with their healthcare providers through a dedicated app, enhancing communication and monitoring efficiency. Distinct from consumer devices that offer ECG recording, Viscero provides high-fidelity, continuous monitoring over extended periods, capable of spanning weeks or months. This innovation marks a significant leap in wearable healthcare technology, presenting a practical, non-invasive solution for long-term heart monitoring.

Related Links:
PA Consulting


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.